Skip to main navigation Skip to search Skip to main content

A Phase II, Multi-Center, Single-Arm, Global Study of MEDI4736 Monotherapy in Patients with Recurrent or Metatatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)

Project: Research

Project Details

StatusFinished
Effective start/end date07/23/1507/22/18

Funding

  • AstraZeneca Pharmaceuticals LP: $8,908.72